Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine TNF receptor superfamily member 17 (TNFRSF17) ELISA Kit-Sandwich

Name: Canine TNF receptor superfamily member 17 (TNFRSF17) ELISA Kit-Sandwich
SKU: EK10F618
Rating: 5 (1 reviews)

Cat. No.EK10F618

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Basket

Product Overview

BioVenic Canine TNFRSF17 ELISA Kit-Sandwich is designed for the quantitative determination of Canine TNFRSF17 in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Canine TNFRSF17.

Target Species Canine

Species Reactivity Canine

Detection Range 32-2000 pg/mL

Sensitivity 6.25 pg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

TNF receptor superfamily member 17 is encoded by the TNFRSF17 gene in dogs. TNFRSF17, also known as B cell maturation antigen, can induce breast cancer cell stemness mediated by B cell activating factor and a proliferation-inducing ligand.

Target/Biomarker Canine TNFRSF17

Target Synonym TNF receptor superfamily member 17; tumor necrosis factor receptor superfamily member 17

Gene ID 100684674

UniProt ID A0A8C0N4C4

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Wu, X.; Liang, Y. Screening and prognostic analysis of immune-related genes in pancreatic cancer. Frontiers in genetics. 2021, 12: 721419.